Transgene SA (EPA:TNG)
0.7400
-0.0260 (-3.39%)
Apr 2, 2026, 5:35 PM CET
Transgene Employees
Transgene had 147 employees as of June 30, 2025.
Employees
147
Change
n/a
Growth
n/a
Revenue / Employee
€49,048
Profits / Employee
€255,265
Market Cap
202.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 147 | - | - |
| Dec 31, 2024 | 144 | 3 | 2.13% |
| Dec 31, 2023 | 141 | -5 | -3.42% |
| Dec 31, 2022 | 146 | 3 | 2.10% |
| Dec 31, 2021 | 143 | 4 | 2.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 174 |
| MedinCell | 145 |
| Adocia | 77 |
| MaaT Pharma | 65 |
| OSE Immunotherapeutics | 64 |
Transgene News
- 10 days ago - Transgene SA (STU:TGNA) Full Year 2025 Earnings Call Highlights: Strategic Financial Moves and ... - GuruFocus
- 10 days ago - Full Year 2025 Transgene SA Earnings Call Transcript - GuruFocus
- 7 months ago - Transgene SA (FRA:TGNA) (Half Year 2025) Earnings Call Highlights: Strategic Focus on TG4050 ... - GuruFocus
- 7 months ago - Half Year 2025 Transgene SA Earnings Call Transcript - GuruFocus
- 1 year ago - Half Year 2024 Transgene SA Earnings Call Transcript - GuruFocus
- 3 years ago - Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio - Business Wire
- 3 years ago - Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration - Business Wire
- 3 years ago - Transgene and BioInvent Joint Paper on BT-001 Wins JITC “Best Oncolytic and Local Immunotherapy Paper” Award for 2022 - Business Wire